Compare CVS Health Corp (CVS) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs MasterCard Inc — how do they compare? CVS Health Corp trades at $106.03 (market cap $135.12B), while MasterCard Inc trades at $539.25 (market cap $475.10B). The key difference: MasterCard Inc is far larger — about 3.5× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | MA | |
|---|---|---|
Market Cap | $135.12B | $475.10B |
Sector | Health | Consumer Cyclical |
52-Week High | $106.18 | $598.96 |
52-Week Low | $58.75 | $471.55 |
Enterprise Value | $201.66B | $485.84B |
Dividend Yield | 2.51% | 0.65% |
Volume | — | 4,635,698 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Mastercard (MA) trades at $537.70, up 2.08% today, with a bullish technical outlook and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue grew to $32.79B in 2025, and net income margin remains robust at 45.88%. Analysts maintain a strong buy consensus, with a price target of $634.27, indicating ~18% upside. Recent news highlights institutional accumulation and AI-driven payment innovations.
The outlook for MA is positive, driven by earnings momentum and strategic expansion into digital payments. Key risks include competitive disruption from stablecoins and regulatory scrutiny. With high profitability and institutional support, the stock presents a growth opportunity, though investors should monitor payment industry evolution and macroeconomic factors affecting consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
